Galedra
Sign in Sign up

Evidence item

The passage directly reports reduced postoperative opioid exposure, unchanged pain interference and physical function, 68,141 procedures, and no worsening of reported safety outcomes. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 19212

Source: September 28, 2026: NOHARM Trial Finds Reduction in Postoperative Opioid Exposure Without Changes in Patient-Reported Outcomes · locator {} · excerpt hash sha256:cc5bcb8038b425d7a17ef046646fbad60160922707a88fb9e8e3c72c8e7e1145

Exact excerpt
In the NOHARM trial, a strategy to promote nondrug pain management after surgery reduced exposure to opioids without worsening pain interference, physical function, and other patient-reported outcomes. ... A total of 68,141 surgical procedures were included in the analysis ... The researchers found no change in patient-reported pain interference and physical function. However, the intervention reduced exposure to opioids after surgery ... These reductions ... were achieved without worsening patient-reported outcomes, opioid-related adverse events, or other safety outcomes.

Linked claims

ClaimDirectionRelevanceStepsCounted
6442452bSUPPORTDIRECT0yes

Audits

None.